Literature DB >> 8312340

Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates.

M G Gagliardi1, M Bevilacqua, C Squitieri, R Boldrini, D P Di Julio, C Marcelletti.   

Abstract

Dilated cardiomyopathy, frequently caused by acute myocarditis, is a common indication for heart transplantation in pediatric patients. The prognosis of children with acute myocarditis is not well known but is believed to be poor. We report the short-term follow-up in 20 pediatric patients (mean age 22 +/- 19 months) with acute myocarditis diagnosed by endomyocardial biopsy. All patients were treated by immunosuppression (cyclosporine and steroids). Endomyocardial biopsy was repeated after 6 months in all patients and after 1 year in patients with persistent acute myocarditis. To evaluate left ventricular function, two-dimensional echocardiography was performed at the time of each endomyocardial biopsy, and left ventricular end-diastolic volume index and ejection fraction were calculated. After 6 months, endomyocardial biopsy showed persistence of acute myocarditis in 13 of 20 patients. After 1 year, endomyocardial biopsy performed in 11 of 13 patients with persistent acute myocarditis showed ongoing acute myocarditis in 10 of 11 patients. On admission to the hospital, 16 of 20 patients had left ventricular dilation (end-diastolic volume index 122 +/- 19 ml/m2; normal values 63 +/- 17 ml/m2) and 20 of 20 had decreased contractility (ejection fraction 34% +/- 11%; normal values 66.1% +/- 5.2%). After 6 months, in all patients the end-diastolic volume index decreased to 73 +/- 23 ml/m2 (p < 0.001), and the ejection fraction increased to 56% +/- 8% (p < 0.000001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8312340

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

1.  Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence.

Authors:  M Burch
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

2.  Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.

Authors:  Biagio A Pietra; Paul F Kantor; Heather L Bartlett; Clifford Chin; Charles E Canter; Ranae L Larsen; R Erik Edens; Steven D Colan; Jeffrey A Towbin; Steven E Lipshultz; James K Kirklin; David C Naftel; Daphne T Hsu
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

3.  Clinical outcomes of acute myocarditis in childhood.

Authors:  K J Lee; B W McCrindle; D J Bohn; G J Wilson; G P Taylor; R M Freedom; J F Smallhorn; L N Benson
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 4.  Diagnosis and management of pediatric myocarditis.

Authors:  Desmond Bohn; Lee Benson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Outcome of acute fulminant myocarditis in children.

Authors:  N Amabile; A Fraisse; J Bouvenot; P Chetaille; C Ovaert
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

Review 6.  Pediatric Myocarditis: What Have We Learnt So Far?

Authors:  Elettra Pomiato; Marco Alfonso Perrone; Rosalinda Palmieri; Maria Giulia Gagliardi
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-03

7.  Predictors of outcome of myocarditis.

Authors:  B Kühn; E D Shapiro; T A Walls; A H Friedman
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

8.  Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.

Authors:  M Giulia Gagliardi; M Bevilacqua; C Bassano; B Leonardi; R Boldrini; F Diomedi Camassei; A Fierabracci; A G Ugazio; G F Bottazzo
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

9.  Heart failure in the young: Insights into myocardial recovery with ventricular assist device support.

Authors:  Eva Maria Javier Delmo; Mariano Francisco Del Maria Javier; Dietmar Böthig; Andre Rüffer; Robert Cesnjevar; Michael Dandel; Roland Hetzer
Journal:  Cardiovasc Diagn Ther       Date:  2021-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.